Cargando…

The Quality of Online Information for an Uncommon Malignancy—Neuroendocrine Tumours (NETs)

Background: Patient information is critical in shared decision-making and patient-centred management for neuroendocrine tumours (NETs). Most adults search the internet for health issues, with over half considering such information to be credible. Therefore, we evaluated the quality of online informa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sohail, Safa, Zuk, Victoria, Halfdanarson, Thorvardur, Chan, Dadvid, Pattison, Sharon, Vasdev, Ravleen, Law, Calvin, Hallet, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985761/ https://www.ncbi.nlm.nih.gov/pubmed/33567619 http://dx.doi.org/10.3390/curroncol28010082

Ejemplares similares

Primary neuroendocrine carcinoma of the brain
por: Reed, Clay T, et al.
Publicado: (2019)

Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies
por: Diamantopoulos, Leonidas N., et al.
Publicado: (2023)

Constrictive bronchiolitis in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
por: Samhouri, Bilal F., et al.
Publicado: (2020)

Radiomics in pulmonary neuroendocrine tumours (NETs)
por: Cozzi, Diletta, et al.
Publicado: (2022)

Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States
por: Shah, Shrunjal, et al.
Publicado: (2021)

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
por: Starr, Jason S, et al.
Publicado: (2020)

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy
por: Halfdanarson, Thorvardur R., et al.
Publicado: (2023)

My burning issues in neuroendocrine tumours (NET)
por: Kiesewetter, Barbara, et al.
Publicado: (2018)

Advances in systemic therapy for advanced pancreatobiliary malignancies
por: Halfdanarson, Thorvardur R, et al.
Publicado: (2013)

Surgical management of neuroendocrine tumour (NET) liver metastases
por: Hellman, Per
Publicado: (2013)

Incidence of and Factors Associated With Nonfatal Self-injury After a Cancer Diagnosis in Ontario, Canada
por: Noel, Christopher W., et al.
Publicado: (2021)

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
por: Ramage, John K, et al.
Publicado: (2011)

A155 OUTCOMES FOLLOWING ENDOSCOPIC RESECTION OF DUODENAL NEUROENDOCRINE TUMOURS FROM A TERTIARY-CARE ACADEMIC CENTRE
por: Gupta, S, et al.
Publicado: (2023)

A156 OUTCOMES FOLLOWING ENDOSCOPIC RESECTION OF GASTRIC NEUROENDOCRINE TUMOURS FROM A TERTIARY-CARE ACADEMIC CENTRE
por: Gupta, S, et al.
Publicado: (2023)

Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012
por: Padrnos, Leslie, et al.
Publicado: (2016)

Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis
por: Sonbol, Mohamad Bassam, et al.
Publicado: (2022)

Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)
por: Megdanova-Chipeva, Vera G., et al.
Publicado: (2020)

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
por: Elston, Marianne S., et al.
Publicado: (2021)

Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care
por: Woodhouse, Braden, et al.
Publicado: (2019)

Incidence and Survival of Patients with Small Intestinal Neuroendocrine Tumours in a Danish NET Center
por: Hoej, Lise Brehm, et al.
Publicado: (2012)

Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms
por: Eads, Jennifer R, et al.
Publicado: (2023)

Pilot Study Characterizing the Hematology-Oncology Fellow Job Search Process: Tools Used and Identification of Potential New Resources
por: Marshall, Ariela L., et al.
Publicado: (2021)

Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors
por: Gudmundsdottir, Hallbera, et al.
Publicado: (2022)

Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference
por: Kennedy, Andrew, et al.
Publicado: (2015)

Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases
por: Venable, Elise R., et al.
Publicado: (2020)

The value of the FDG-GaTate and proliferation marker (ki-67) in the assessment of neuroendocrine tumours (NETs)
por: Fikri, AS Fathinul, et al.
Publicado: (2015)

Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States
por: Abdelrahman, Amro M., et al.
Publicado: (2023)

Adult granulosa cell tumour of the testis: an uncommon tumour
por: Wahlstedt, Eric R, et al.
Publicado: (2022)

Mr. Wainwright, on an Uncommon Tumour of the Abdomen
por: Wainwright, Thomas
Publicado: (1799)

Targeted Alpha-Particle Therapy: A Review of Current Trials
por: Jang, Albert, et al.
Publicado: (2023)

Malignant Proliferating Trichilemmal Tumour Presenting Early in Life: An Uncommon Feature
por: Rao, Shalinee, et al.
Publicado: (2011)

Reproducibility of CT radiomic features in lung neuroendocrine tumours (NETs) patients: analysis in a heterogeneous population
por: Bicci, Eleonora, et al.
Publicado: (2023)

Neuroendocrine tumours and their microenvironment
por: de Hosson, Lotte D., et al.
Publicado: (2020)

Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours
por: Söderquist, Fanny, et al.
Publicado: (2016)

Hedinger syndrome due to advanced malignant neuroendocrine tumour
por: Ackerschott, Ansgar, et al.
Publicado: (2023)

Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms
por: Al-Toubah, T., et al.
Publicado: (2021)

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)
por: Sowa-Staszczak, Anna, et al.
Publicado: (2011)

Updated Principles of Surgical Management of Pancreatic Neuroendocrine Tumours (pNETs): What Every Surgeon Needs to Know
por: de Ponthaud, Charles, et al.
Publicado: (2021)

Casting a Wider NET: Pancreatic Exocrine Insufficiency Induced by Somatostatin Analogues among Patients with Neuroendocrine Tumours?
por: Hall, Lewis A., et al.
Publicado: (2023)

Uncommon presentation of a less common tumour
por: Vinay, Keshavamurthy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_isvuj8gi4e5ec1fp0bo3tu7op3